1. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. (November 2018) Authors: Veenstra, V.; Damhofer, H.; Waasdorp, C.; Rijssen, L.; Vijver, M.; Dijk, F.; Wilmink, H.; Besselink, M.; Busch, O.; Chang, D.; Bailey, P.; Biankin, A.; Kocher, H.; Medema, J.; Li, J.; Jiang, R.; Pierce, D.; Laarhoven, H.; Bijlsma, M. Journal: Oncogenesis Issue: Volume 7(2018:Nov.) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗